TTM
35.5%
YoY change
+2.34pp
Trough year (1999)
-169.8%
Peak year (2012)
43.0%
Latest annual
36.0%
EBITDA Margin history chart for Intuitive Surgical (ISRG) from 1999 to 2025
Latest: 36.0%
EBITDA Margin change chart for Intuitive Surgical (ISRG) from 1999 to 2025
Latest: +2.34pp
EBITDA Margin history table for Intuitive Surgical (ISRG) from 1999 to 2025
| 2025 | 36.0% | +2.34pp | ||
| 2024 | 33.7% | +3.21pp | ||
| 2023 | 30.4% | -0.78pp | ||
| 2022 | 31.2% | -6.10pp | ||
| 2021 | 37.3% | +6.90pp | ||
| 2020 | 30.4% | -4.80pp | ||
| 2019 | 35.2% | -0.28pp | ||
| 2018 | 35.5% | -1.50pp | ||
| 2017 | 37.0% | -1.84pp | ||
| 2016 | 38.9% | +4.06pp | ||
| 2015 | 34.8% | +5.54pp | ||
| 2014 | 29.2% | -11.36pp | ||
| 2013 | 40.6% | -2.35pp | ||
| 2012 | 43.0% | +0.77pp | ||
| 2011 | 42.2% | +0.03pp | ||
| 2010 | 42.2% | +2.99pp | ||
| 2009 | 39.2% | +0.76pp | ||
| 2008 | 38.4% | +1.82pp | ||
| 2007 | 36.6% | -1.69pp | ||
| 2006 | 38.3% | +5.06pp | ||
| 2005 | 33.2% | +12.83pp | ||
| 2004 | 20.4% | +21.75pp | ||
| 2003 | -1.4% | +20.39pp | ||
| 2002 | -21.8% | +8.57pp | ||
| 2001 | -30.3% | +35.50pp | ||
| 2000 | -65.8% | +103.98pp | ||
| 1999 | -169.8% | — |
- 202536.0%+2.34pp
- 202433.7%+3.21pp
- 202330.4%-0.78pp
- 202231.2%-6.10pp
- 202137.3%+6.90pp
- 202030.4%-4.80pp
- 201935.2%-0.28pp
- 201835.5%-1.50pp
- 201737.0%-1.84pp
- 201638.9%+4.06pp
- 201534.8%+5.54pp
- 201429.2%-11.36pp
- 201340.6%-2.35pp
- 201243.0%+0.77pp
- 201142.2%+0.03pp
- 201042.2%+2.99pp
- 200939.2%+0.76pp
- 200838.4%+1.82pp
- 200736.6%-1.69pp
- 200638.3%+5.06pp
- 200533.2%+12.83pp
- 200420.4%+21.75pp
- 2003-1.4%+20.39pp
- 2002-21.8%+8.57pp
- 2001-30.3%+35.50pp
- 2000-65.8%+103.98pp
- 1999-169.8%—
EBITDA Margin values are taken from Intuitive Surgical's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA Margin at Intuitive Surgical (ISRG)
According to Intuitive Surgical's latest reported financial statements, the company's latest reported EBITDA margin is 35.5%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Intuitive Surgical (ISRG) EBITDA margin is 35.99% – expanded 2.3 percentage points year-over-year.
2012 marks the peak EBITDA margin at 42.95%, with the historical low of -169.80% recorded in 1999.
Intuitive Surgical EBITDA Margin by Year
Intuitive Surgical EBITDA Margin 2025: 36.0%
Intuitive Surgical posted EBITDA margin of 35.99% in 2025, expanded 2.3 percentage points from 2024.
Intuitive Surgical EBITDA Margin 2024: 33.7%
In 2024, Intuitive Surgical reported EBITDA margin of 33.66%, expanded 3.2 percentage points from 2023.
Intuitive Surgical EBITDA Margin 2023: 30.4%
Intuitive Surgical EBITDA margin in 2023 was 30.45%, contracted 0.8 percentage points from 2022.
Intuitive Surgical EBITDA Margin 2022: 31.2%
2022's EBITDA margin for Intuitive Surgical came in at 31.23%, contracted 6.1 percentage points from 2021.
Intuitive Surgical EBITDA Margin 2021: 37.3%
Intuitive Surgical EBITDA margin in 2021 was 37.32%.
See more financial history for Intuitive Surgical (ISRG).
Sector peers by EBITDA Margin
Healthcare peers of Intuitive Surgical (ISRG), ranked by their latest EBITDA margin
| 55.4% | |
| 46.6% | |
| 45.9% | |
| 34.6% | |
| 33.9% | |
| 30.3% | |
| 26.9% | |
| 5.1% |
- 55.4%
- 46.6%
- 45.9%
- 34.6%
- 33.9%
- 26.9%
Frequently asked questions
Intuitive Surgical (ISRG) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation